New approaches to prevent intestinal toxicity of irinotecan-based regimens

This publication has 37 references indexed in Scilit:

• Mathematics and Oncology: A Match for Life?
  Journal of Clinical Oncology, 2003
• Optimizing the Use of Irinotecan in Colorectal Cancer
  The Oncologist, 2001
• Recommendation for Caution with Irinotecan, Fluorouracil, and Leucovorin for Colorectal Cancer
  New England Journal of Medicine, 2001
• Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer
  The Lancet, 1998
• Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer
  The Lancet, 1998
• Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes.
  Journal of Clinical Investigation, 1998
• Relevance of Irinotecan Hydrochloride-Induced Diarrhea to the Level of Prostaglandin E2 and Water Absorption of Large Intestine in Rats
  The Japanese Journal of Pharmacology, 1997
• Re: Irinotecan (CPT-11) and Characteristic Mucosal Changes in the Mouse Ileum and Cecum
  JNCI Journal of the National Cancer Institute, 1996
• Irinotecan (CPT-11) and Characteristic Mucosal Changes in the Mouse Ileum and Cecum
  JNCI Journal of the National Cancer Institute, 1995
• Protective Effects of Kampo Medicines and Baicalin against Intestinal Toxicity of a New Anticancer Camptothecin Derivative, Irinotecan Hydrochloride (CPT‐11), in Rats
  Japanese Journal of Cancer Research, 1995